CLINICAL_TRIALS
research
· 2009-09-24
Clinical Trial Update: A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus [Phase 2]
Summary
A Phase 2 clinical study of GRC 8200 for Type 2 Diabetes Mellitus is being conducted, with current status not specified.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Glenmark Pharmaceuticals Europe Ltd. (R&D) | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: UNKNOWN